BridgeBio Oncology Therapeutics, Inc. · NASDAQ:BBOT
Cobo Marc sold 78 BridgeBio Oncology Therapeutics, Inc. shares (Form 4)
Traded Nov 13, 2026 · Filed Nov 17, 2026
On Nov 13, 2026, Cobo Marc (Principal Accounting Officer) sold 78 BridgeBio Oncology Therapeutics, Inc. shares at US$2.37 for US$185 under a trading plan, leaving 13,734 shares. Filed Nov 17, 2026 (Form 4).
- Sold
- 78 shares
- Price
- US$2.37
- Value
- US$185
- Holding after
- 13,734 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Principal Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | Common Stock | Sale | 78 | US$2.37 | 13,734 | Direct |
Source
Download original · View original at SEC
Related
- BridgeBio Oncology Therapeutics, Inc.
- Cobo Marc
- BridgeBio Oncology Therapeutics, Inc. shareholders
- Form 4 · Cobo Marc · Oct 23, 2026
- Form 4 · Cobo Marc · Oct 5, 2026
- Form 4 · Cobo Marc · Sep 14, 2026
- Form 4 · Cobo Marc · Jul 6, 2026
- Form 4 · Beltran Pedro · Nov 20, 2026
- Schedule 13G/A · Deerfield Management Company, L.P. · Nov 13, 2026
- Form 4 · Beltran Pedro · Oct 5, 2026
- Form 4 · Ben Yong · Oct 5, 2026
- Form 4 · Elmelech Idan · Oct 5, 2026